Trivium Point Advisory LLC increased its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 55.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,535 shares of the enterprise software provider's stock after purchasing an additional 19,196 shares during the quarter. Oracle makes up about 1.3% of Trivium Point Advisory LLC's portfolio, making the stock its 9th largest holding. Trivium Point Advisory LLC's holdings in Oracle were worth $11,704,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also added to or reduced their stakes in ORCL. Nuveen LLC bought a new stake in shares of Oracle during the first quarter worth $732,692,000. Vanguard Group Inc. grew its stake in shares of Oracle by 2.2% during the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock worth $22,498,982,000 after buying an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC bought a new stake in shares of Oracle during the second quarter worth $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Oracle by 79.2% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider's stock worth $648,572,000 after buying an additional 2,049,687 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in shares of Oracle by 840.7% during the second quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider's stock worth $463,380,000 after buying an additional 1,894,157 shares during the last quarter. Institutional investors own 42.44% of the company's stock.
Oracle Stock Down 0.3%
Oracle stock opened at $282.68 on Tuesday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The firm's fifty day moving average is $258.97 and its 200 day moving average is $202.09. The company has a market capitalization of $803.29 billion, a PE ratio of 65.44, a PEG ratio of 3.05 and a beta of 1.46.
Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. During the same quarter in the previous year, the firm earned $1.39 EPS. The firm's revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, sell-side analysts predict that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle's payout ratio is presently 46.30%.
Insider Activity at Oracle
In other Oracle news, insider Michael D. Sicilia sold 33,845 shares of the company's stock in a transaction on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the transaction, the insider owned 132,656 shares in the company, valued at approximately $42,603,800.96. This represents a 20.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Clayton M. Magouyrk sold 21,241 shares of the company's stock in a transaction on Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the transaction, the insider owned 78,000 shares in the company, valued at approximately $23,174,580. The trade was a 21.40% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 112,092 shares of company stock worth $32,960,165 over the last ninety days. 42.20% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on ORCL shares. Berenberg Bank boosted their target price on shares of Oracle from $202.00 to $306.00 and gave the stock a "hold" rating in a research note on Monday, September 15th. DA Davidson boosted their target price on shares of Oracle from $220.00 to $300.00 and gave the stock a "neutral" rating in a report on Wednesday, September 10th. Redburn Partners set a $175.00 target price on shares of Oracle in a report on Thursday. Mizuho boosted their target price on shares of Oracle from $300.00 to $350.00 and gave the stock an "outperform" rating in a report on Wednesday, September 10th. Finally, Barclays boosted their target price on shares of Oracle from $221.00 to $281.00 and gave the stock an "overweight" rating in a report on Monday, September 8th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Oracle has a consensus rating of "Moderate Buy" and a consensus price target of $304.71.
Get Our Latest Stock Report on ORCL
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report